Breaking Down the Cost of Sickle Cell Disease Gene Therapies
- Earlier this week, the Biden–Harris administration announced its plans to address the expensive price tag of sickle cell disease, looking for a way to widen access despite the cost. In an announcement by the United States Centers for Medicare and Medicaid Services (CMS), the organization noted that sickle cell disease will be the first focus...
